FDA rejects PTC’s DMD drug Translarna
admin 26th October 2017 Uncategorised 0PTC Therapeutics will need to carry out at least one further trial to demonstrate the effectiveness of its Duchenne Muscular Dystrophy therapy Translarna if it is to have a chance of bagging its approval in the US.
More: FDA rejects PTC’s DMD drug Translarna
Source: News